comparemela.com

Latest Breaking News On - Y21 - Page 7 : comparemela.com

Astellas Pharma FY21 Core Profit Decreases; Revenue Up 3 7%

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) reported that its fiscal 2021 core operating profit decreased by 2.6% year-on-year to 244.7 billion yen, and core profit

Ferrexpo FY21 Earnings Rise

LONDON (dpa-AFX) - Ferrexpo Plc (FXPO.L), a Swiss iron ore pellet producer, on Friday posted a rise in earnings for the fiscal 2021, reflecting a rise revenue. For the fiscal 2021, the Baar-headquartered

EQS-Adhoc: Evolva Holding SA: Evolva achieves important product-related milestones with global customer, triggering revenues of more than 20% of FY21 total revenues

Evolva Holding SA / Key word(s): Development of Sales Evolva achieves important product-related milestones with global customer, triggering revenues of more than 20% of FY21 total revenues 20-Apr-2022

John Wood Group FY21 Adj Profit Declines; Robin Watson Plans To Retire As Chief Executive

LONDON (dpa-AFX) - Wood Group (John) PLC (WDGJF.PK, WG.L) reported that its fiscal 2021 adjusted EBITDA declined 10% on a like-for-like basis, with improved EBITDA in Consulting offset by lower

Oxford BioMedica Turns To Profit In FY21; Sees Growth In FY22

LONDON (dpa-AFX) - Oxford Biomedica plc (OXB.L), a gene and cell therapy group, reported Wednesday that its fiscal 202 net profit was 19 million pounds, compared to last year's loss of 6.2 million

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.